Home
Live Updates
Guardant Health, Inc.: Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications : comparemela.com
Guardant Health, Inc.: Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption
Related Keywords
Meldola ,
Emilia Romagna ,
Italy ,
Germany ,
Michael Weist ,
Nicola Normanno ,
Zarak Khurshid ,
Dino Amadori ,
Helmy Eltoukhy ,
Peter Fasching ,
Gynecological Cancer Center ,
Nasdaq ,
Cancer Center ,
Guardant Health Inc ,
National Comprehensive Cancer Network ,
Facebook ,
Exchange Commission ,
Linkedin ,
European Union In Vitro Diagnostic Regulation ,
Breast Cancer Center ,
Guardant Health ,
D Product Service ,
Romagna Institute For The Study Of Tumors ,
European Union ,
Vitro Diagnostic Regulation ,
Comprehensive Cancer Center ,
Financial Condition ,
Annual Report ,
Bangy J ,
Safety Data ,
Positive Advanced Non Small Cell Lung Cancer ,
Global Phase ,
Next Generation Sequencing ,
Non Small Cell Lung ,
Molecular Analyses Guide Efforts ,
Prospective Study ,
Molecular Profiling ,
Metastatic Triple Negative Breast ,
Circulating Tumor ,
Matched Metastatic Tissue Biopsy ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.